WinstonWınston
Lancer Orthodontics logo

Lancer Orthodontics

LANZ
29
Medical - Specialties · Healthcare
Price
$0.04
+0.00 (+0.00%)
Market Cap
$110,352
Winston Score
29
Winston is worried
Below-average fundamentals — multiple weak pillars.

Share count rising — dilution

+26.1% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 2.0M (2000) → 2.5M (2004)

Lancer Orthodontics makes dental products used by orthodontists — the dentists who straighten teeth. Its core products include metal and ceramic braces, brackets, wires, and other tools that orthodontists use every day in their clinics. The company sells directly to dental professionals, placing it in the specialized medical supplies market.

Lancer generates revenue by selling these orthodontic supplies to dental practices, primarily in the United States but also in international markets. It is a small company with a market cap near zero, meaning it competes against much larger players like 3M and Dentsply Sirona, which have stronger brand recognition and bigger distribution networks. The main risk the company faces is margin pressure — with a gross margin around 31% and an operating margin barely above zero, there is very little room for error, and any cost increases or pricing competition could push the business into a loss.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-5.6% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+261.4% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$116,104/ year

Rising (+8% vs prior year)

1.9% of revenue

Below sector average (18%)

R&D investment increasing — building for the future

Insider Activity

6.6%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~23 months

$304,145 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Adequate runway but may need to raise capital within 2 years

Revenue declining

Lancer Orthodontics's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
39.9%
Modest — 39.9% gross margin
Operating Margin
-3.8%
Losing money on operations — -3.8%
ROCE
-1.6%
Weak — -1.6% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+5.1%
Slow sales growth (5.1% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
-52%
Weak — only -52% of profit becomes cash
FCF Margin
-6.8%
Burning cash (-6.8%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
N/A
Data not available
Interest Cover
57.93x
Comfortably covers interest (57.9x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
0.6x
Attractive valuation — P/E 0.6

P/E under 10. The price tag is small relative to last year's profit.

P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial